Understanding Extra-Coronary Calcification: A New Risk Factor for Women

Cardiovascular disease (CVD) remains the leading cause of death among women globally, yet traditional risk calculators often underestimate their risk, particularly for those classified as low or intermediate risk. Recent studies have highlighted the importance of extra-coronary calcification (ECC) as a significant adjunctive imaging biomarker for assessing cardiovascular risk in women. ECC includes breast arterial calcification, valvular calcification, and thoracic aortic calcification, all of which can be detected through routine imaging techniques such as mammography and echocardiography. Research indicates that the processes behind vascular and valvular calcification are influenced by various factors, including inflammation, osteogenic signaling pathways, and sex hormones. Unique female factors, such as menopause, pregnancy complications, and parity, further complicate these processes. Notably, ECC has been shown to be independently associated with serious cardiovascular conditions, including coronary artery disease, stroke, heart failure, atrial fibrillation, and even cardiovascular mortality. This association is particularly pronounced in women whose risk may be underestimated by conventional risk assessment tools. For women, recognizing ECC could enhance cardiovascular risk assessment and preventive care. The incidental detection of ECC through existing imaging methods provides a cost-effective and low-radiation opportunity to identify at-risk individuals. However, the integration of ECC metrics into cardiovascular guidelines has been hindered by inconsistencies in recognition, lack of standardized scoring, and limited prospective outcome data. Future research should focus on establishing standardized reporting and utilizing advanced technologies, such as artificial intelligence, to quantify ECC effectively. In terms of practical implications, women should be aware of the potential for ECC to indicate higher cardiovascular risk, especially if they fall into traditionally low-risk categories. Regular screenings that include imaging for ECC could be beneficial, and discussing these options with healthcare providers may lead to better preventive strategies. Additionally, lifestyle modifications that address inflammation and promote vascular health, such as adopting a low-carb or ketogenic diet, may help mitigate risks associated with ECC. In connection to biomarkers, ECC can be linked to several metabolic health indicators. For instance, inflammation markers like hsCRP may correlate with the presence of ECC, while lipid profiles, including triglycerides and HDL levels, can also provide insights into cardiovascular health. Monitoring these biomarkers through Metabolicum's calculators can help individuals understand their risk levels and take proactive steps toward improving their metabolic health. In conclusion, the emerging role of ECC as a cardiovascular risk marker for women underscores the need for enhanced awareness and preventive strategies. By recognizing the significance of ECC and incorporating it into routine assessments, we can better identify at-risk individuals and improve cardiovascular outcomes. Women should engage in discussions with their healthcare providers about the implications of ECC and consider regular screenings as part of their health journey.